| 14197-60-5 Basic information More.. |
Product Name: | Ginsenoside Rg3 | Synonyms: | beta-d-glucopyranoside,(3-beta,12-beta)-12,20-dihydroxydammar-24-en-3-yl2-o-b;dammar-24-ene-12-beta,20-diol,3-beta-((2-o-beta-d-glucopyranosyl-beta-d-gluc;eta-d-glucopyranosyl-;gensenoside RG3;(3β,12β)-12,20-Dihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside;Rg3;GINSENOSIDE RG3;opyransoyl)oxy)- | CAS: | 14197-60-5 | MF: | C42H72O13 | MW: | 785.03 | EINECS: | | Mol File: | 14197-60-5.mol | |
- Ginsenoside Rg3
-
- US $0.00 / kg
- 2024-04-12
- CAS:14197-60-5
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 2000ton
- Ginsenoside Rg3
-
- US $0.00 / mg
- 2023-02-24
- CAS:14197-60-5
- Min. Order: 5mg
- Purity: ≥96%(HPLC)
- Supply Ability: 10 g
|
14197-60-5
Recommend Suppliers |
Company Name: |
Labnetwork lnc.
Recommend
Complaint |
|
Tel: |
+86-27-50766799 |
FAX: |
|
Email: |
contact@labnetwork.com |
Nationality: |
China |
Products Intro: |
Product Name:(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol CAS:14197-60-5 Purity:95% Package:100g; 1kg Remarks:LN01326616 |
CB Index: |
58 |
WebSite: |
www.labnetwork.com |
Related Information: |
Sales Network
Catalog(19994)
User Evaluation
|
|
|
|
|
Company Name: |
Amadis Chemical Company Limited
Recommend
Complaint |
|
Tel: |
571-89925085 |
FAX: |
0086-571-89925065 |
Email: |
sales@amadischem.com |
Nationality: |
China |
Products Intro: |
Product Name:2-[[4,5-dihydroxy-2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)-3-oxany CAS:14197-60-5 Purity:0.97 Package:mgs,gs,kgs Remarks:A807838 |
CB Index: |
58 |
WebSite: |
http://www.amadischem.com |
Related Information: |
Sales Network
Catalog(131980)
User Evaluation(2)
|
|
|
|
|
|